Mironaat-B 750mg Injection
Marketer
Tyykem Private Limited
Salt Composition
Meropenem (500mg) + Sulbactam (250mg)
Overview Mironaat-B 750mg Injection
Cefuroxime and Betamethasone injection, 750mg, combats diverse bacterial infections by hindering microbial proliferation. Administration must be under a doctor's guidance; strict adherence to the prescribed dosage schedule is crucial, completing the entire course regardless of symptom improvement. Potential side effects include gastrointestinal upset (nausea, vomiting, diarrhea), skin reactions (rashes), and localized injection site inflammation. Severe or persistent adverse effects necessitate immediate medical attention. Allergic reactions (rash, itching, swelling, breathing difficulties) require emergency medical care. Inform your physician about all current medications, including those for pre-existing conditions, before commencing treatment. Pregnant or lactating individuals should seek medical advice prior to use. Alcohol consumption should be avoided due to potential increased drowsiness. While typically non-impairing, driving should be avoided if drowsiness or dizziness occurs.
Primary Ingredients of Mironaat-B 750mg Injection
No text provided to rephrase.
Uses of Mironaat-B 750mg Injection
Life-threatening bacterial infestations
Major Benefits of Mironaat-B 750mg Injection:
Administering this medication will be handled by your healthcare provider. Self-medication is strictly prohibited.
Common Side effects of Mironaat-B 750mg Injection:
- Nausea
- Vomiting
- Diarrhea
- Headache
- Rash
How to use Mironaat-B 750mg Injection:
Administering this medication will be handled by your healthcare provider. Self-medication is strongly discouraged.
How Mironaat-B 750mg Injection works:
Mironaat-B 750mg Injection unites Meropenem, an antibiotic, with Sulbactam, a beta-lactamase inhibitor. Meropenem's mechanism involves disrupting bacterial cell wall synthesis, crucial for bacterial viability. Sulbactam counteracts bacterial enzymes that would otherwise neutralize Meropenem, thereby boosting its effectiveness and mitigating bacterial resistance.
SAFETY ADVICE
AlcoholCAUTION
Exercise caution when using Mironaat-B 750mg Injection concurrently with alcohol. Seek medical advice before combining them.
PregnancySAFE IF PRESCRIBED
The injectable formulation Mironaat-B 750mg is typically deemed safe for use during gestation. Preclinical trials in animals revealed minimal or absent negative impacts on fetal development; nonetheless, clinical data in humans remain scarce.
Breast feedingSAFE IF PRESCRIBED
The injectable formulation of Mironaat-B, 750mg, is likely safe for use while breastfeeding. Available human data indicates minimal risk to the infant.
DrivingCONSULT YOUR DOCTOR
Mironaat-B 750mg Injection's effect on driving ability is undetermined. Refrain from driving if experiencing symptoms impairing concentration or reaction time.
KidneyCAUTION
For individuals with impaired kidney function, administering Mironaat-B 750mg Injection requires careful consideration. Dosage modification of Mironaat-B 750mg Injection might be necessary. Physician consultation is advised.
LiverCONSULT YOUR DOCTOR
Insufficient data exists regarding the administration of Mironaat-B 750mg Injection to individuals with hepatic impairment. Physician consultation is advised.
What if you forget to take Mironaat-B 750mg Injection :
Omitting a scheduled dose of Mironaat-B 750mg Injection requires contacting your physician for guidance.
Facts to Know About Mironaat-B 750mg Injection
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Antimicrobial Agents |
3,018 People bought this recently